← Back to headlines
Annexon Biosciences (ANNX) Stock Retains Buy Rating
Financial analysts have reaffirmed a "Buy" rating for Annexon Biosciences (ANNX) stock. This indicates continued confidence in the company's financial prospects and investment potential.
21 Apr, 21:14 — 21 Apr, 21:14
Sources
Showing 1 of 1 sources
